Which market structure is best suited for the pharmaceutical industry (perfect competition, monopolistic competition, monopoly and oligopoly)
If the industry decided to operate under one of the other three remaining marker structure, how would equilibrium price and equilibrium quantity differ? Would it be higher, lower, the same? Why